---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-002669"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T08:35:10.862059+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences raises over $125M from warrant exercises; ~5.7M shares at $22

## Summary
- Gross proceeds over $125M from cash exercises of warrants; ~5.7M common shares issued at $22.00 per share.
- Net proceeds estimated at over $123M after advisory fees and expenses.
- Proceeds to fund working capital and continued development of Alzheimer's drug simufilam.
- Warrants distributed to shareholders, last exercise deadline May 6, 2024; remaining warrants redeemed at $0.001 each.
- B. Dyson Capital Advisors acted as exclusive financial advisor on the warrant distribution.

## SEC filing metadata
- accession: 0001171843-24-002669
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000117184324002669/0001171843-24-002669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000117184324002669/f8k_050824.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-002669
- JSON: https://secwatch.observer/filing/0001171843-24-002669.json
- Plain text: https://secwatch.observer/filing/0001171843-24-002669.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.